ERBB2 and neoplasm: Classical clinico-pathological indicators of patients’ prognosis include tumor size, lymph node metastases, histopathological subtype, tumor grade, lymphovascular invasion, immuno-histochemical evaluation of hormone receptors, HER2 status and proliferation using Ki67 assessment.